Methods and compositions for targeting underglycosylated proteins across the blood brain barrier

Details for Australian Patent Application No. 2008200706 (hide)

Owner ZyStor Therapeutics, Inc.

Inventors Sly, William S; Lebowitz, Jonathan H.

Agent Pizzeys

Pub. Number AU-B-2008200706

Parent 2002362930

Filing date 14 February 2008

Wipo publication date 6 March 2008

Acceptance publication date 27 May 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/65 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/18 (2006.01) Mutation or genetic engineering

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

6 March 2008 Application Open to Public Inspection

  Published as AU-B-2008200706

6 March 2008 Complete Application Filed

27 May 2010 Application Accepted

  Published as AU-B-2008200706

23 September 2010 Standard Patent Sealed

24 March 2011 Assignment Registered

  ZyStor Therapeutics, Inc. The patent has been assigned to BioMarin Pharmaceutical Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008200707-Systems and methods using a solvent for the removal of lipids from fluids

2008200705-Flange Connection System